Related Experiment Video

Updated: Feb 24, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.7K

Lessons from CTLA-4 deficiency and checkpoint inhibition

Bernice Lo1, Ussama M Abdel-Motal1

  • 1Division of Translational Medicine, Research Branch, Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar.

Current Opinion in Immunology
|August 15, 2017
PubMed

Insights

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) regulates immune responses. Its deficiency, caused by mutations or immunotherapy, can lead to severe autoimmunity and tissue damage, with microbiota influencing these effects.

Area of Science:

  • Immunology
  • Autoimmunity
  • Molecular Biology

Background:

  • Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a key negative regulator of immune responses.
  • CTLA-4 deficiency in mice results in fatal autoimmunity and widespread tissue destruction.
  • Recent discoveries link heterozygous CTLA4 or biallelic LRBA mutations to functional CTLA-4 deficiency and autoimmune conditions.

Purpose of the Study:

  • To investigate the role of LRBA in regulating CTLA-4 protein levels.
  • To understand the mechanisms behind autoimmune reactions observed in CTLA-4 deficient individuals and those undergoing checkpoint blockade therapy.
  • To explore the influence of the microbiota on CTLA-4-regulated antitumor and autoreactive immune responses.

Main Methods:

  • Analysis of genetic mutations (heterozygous CTLA4, biallelic LRBA) associated with CTLA-4 deficiency.
  • Investigation of CTLA-4 protein levels in regulatory T cells (Tregs) and activated T cells.
  • Studies on checkpoint blockade cancer immunotherapy and associated autoimmune responses.
  • Exploration of the role of gut microbiota in modulating immune responses.

Main Results:

  • LRBA has been identified as a novel regulator of CTLA-4 protein stability in T cells.
  • Functional CTLA-4 deficiency, whether genetic or therapy-induced, is strongly associated with autoimmune manifestations.
  • The microbiota plays a significant role in modulating both antitumor efficacy and autoimmune reactions driven by CTLA-4.

Conclusions:

  • LRBA is essential for maintaining adequate CTLA-4 levels, crucial for immune homeostasis.
  • Dysregulation of CTLA-4 function contributes to autoimmunity, highlighting its importance in immune tolerance.
  • Microbiota-immune interactions are critical determinants of outcomes in CTLA-4-targeted therapies and autoimmune diseases.

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.6K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K